| Title: |
URGENT ACTION – Trial 41 dissemination |
|
Document Date:
|
20020910
|
|
Document Type:
|
email
|
|
Case Number:
|
Seroquel Products Litigation, 06-MD-01769, US District Court, Middle District of Florida
|
|
Bates Number:
|
azser3777919-20
|
|
Exhibit Number:
|
Beamish 27
|
|
Date Added UCSF:
|
20100218
|
|
Page Count:
|
2
|
|
Description:
|
Transparency/Concealing Data; Efficacy; Study 41; Email from Seroquel Global Brand Manager, Simon Hagger, on behalf of the Seroquel SR Communications Team advising that they are under clear instruction from the highest level in AZ not to discuss details surrounding Trial 41 with any external partners, which would include study investigators.
|
|
Company:
|
AstraZeneca
|
| View as: |
PDF |
|
Bookmark:
|
http://dida.library.ucsf.edu/tid/tgv09b10
|
|
